Cargando…

Circulating C-X-C Motif Ligand 13 as a Biomarker for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With Chronic Allergic Rhinitis

BACKGROUND: C-X-C motif ligand 13 (CXCL13) and B cell-activating factor (BAFF) are proven to be involved in inflammatory diseases, but their role in allergic rhinitis (AR) remains unclear. The aim of this study was to investigate the role of serum CXCL13 and BAFF in AR and their clinical values as o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Shenghao, Wen, Sihui, Xie, Shaobing, Zhang, Caixia, Zhang, Hua, Gao, Kelei, Fan, Ruohao, Xie, Zhihai, Jiang, Weihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114669/ https://www.ncbi.nlm.nih.gov/pubmed/35601415 http://dx.doi.org/10.3389/fped.2022.872152

Ejemplares similares

Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis
por: Wen, Sihui, et al.
Publicado: (2022)

Exosomes Derived hsa-miR-4669 as a Novel Biomarker for Early Predicting the Response of Subcutaneous Immunotherapy in Pediatric Allergic Rhinitis
por: Jiang, Sijie, et al.
Publicado: (2022)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
por: Xie, Shaobing, et al.
Publicado: (2022)

Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
por: Xie, Shaobing, et al.
Publicado: (2021)

Identification of Novel Biomarkers for Evaluating Disease Severity in House-Dust-Mite-Induced Allergic Rhinitis by Serum Metabolomics
por: Xie, Shaobing, et al.
Publicado: (2021)

Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
por: Jiang, Sijie, et al.
Publicado: (2023)

The Role of Noncoding RNA in Airway Allergic Diseases through Regulation of T Cell Subsets
por: Cheng, Shenghao, et al.
Publicado: (2022)

Serum YKL-40 Levels Predict Endotypes and Associate with Postoperative Recurrence in Patients with Chronic Rhinosinusitis with Nasal Polyps
por: Wen, Sihui, et al.
Publicado: (2021)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Allergic Rhinitis as an Independent Risk Factor for Postoperative Recurrence of Children Chronic Sinusitis
por: Zhang, Caixia, et al.
Publicado: (2023)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Investigation of Allergic Sensitizations in Children With Allergic Rhinitis and/or Asthma
por: Dai, Lingman, et al.
Publicado: (2022)

The Role of Serum Metabolomics in Distinguishing Chronic Rhinosinusitis With Nasal Polyp Phenotypes
por: Xie, Shaobing, et al.
Publicado: (2021)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Elevated ALCAM Expression Associated with Endotypes and Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps
por: Zhang, Hua, et al.
Publicado: (2022)

Recent Updates of Immunotherapy for Allergic Rhinitis in Children
por: Lin, Chih-Feng, et al.
Publicado: (2023)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
por: Endaryanto, Anang, et al.
Publicado: (2022)

Tidal Breathing Pulmonary Function of Children With Allergic Rhinitis
por: Du, Hui, et al.
Publicado: (2022)

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)

Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice
por: Blume, Steven W., et al.
Publicado: (2015)

Investigation of the allergens in 2,316 children with allergic rhinitis from Guangdong, China
por: Zhang, Nannan, et al.
Publicado: (2022)

Association of Asthma and Allergic Rhinitis With Sleep-Disordered Breathing in Childhood
por: Perikleous, Evanthia, et al.
Publicado: (2018)

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
por: Zheng, Chen, et al.
Publicado: (2023)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
por: Huang, Jingyu, et al.
Publicado: (2023)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
por: Zheng, Peiyan, et al.
Publicado: (2021)

Visual analysis of allergic rhinitis in children based on web of science and CiteSpace software
por: Liu, Fang, et al.
Publicado: (2022)

Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients
por: Sousa, Letícia, et al.
Publicado: (2018)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis
por: Shen, Zhiying, et al.
Publicado: (2019)

Efficacy of subcutaneous immunotherapy for patients with asthma and allergic rhinitis in Korea: effect on eosinophilic inflammation
por: Kim, Chang Keun, et al.
Publicado: (2021)

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2022)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Preliminary Efficacy Report and Prognosis Analysis of Endoscopic Endonasal Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma
por: Peng, Zhouying, et al.
Publicado: (2021)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v1ejt6m0ga5ssdv002e4aba8sc